Hillevax Inc

NASDAQ HLVX

Data sourced from

and

Download Data

Hillevax Inc Dividend Payout Ratio for the Trailing 12 Months (TTM) ending March 31, 2024

Hillevax Inc Dividend Payout Ratio is NA for the Trailing 12 Months (TTM) ending March 31, 2024. The dividend payout ratio measures the percentage of a company's net income that is distributed as dividends to shareholders. It is calculated by dividing dividends paid by net income. This ratio provides insights into the portion of earnings that is returned to shareholders in the form of dividends. A higher ratio indicates a larger proportion of earnings being paid out as dividends.

NASDAQ: HLVX

Hillevax Inc

CEO	Dr. Robert M. Hershberg M.D., Ph.D.
IPO Date	April 29, 2022
Location	United States
Headquarters	75 State Street, Boston, MA, United States, 02109
Employees	90
Sector	Healthcare
Industry	Biotechnology

Description

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Key trends